Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Pharmaceuticals 2011, 4(1), 154-168; doi:10.3390/ph4010154
Review

Cardiorenal Effects of Kappa Opioid Peptides During Ontogeny

*  and
Received: 9 December 2010; in revised form: 30 December 2010 / Accepted: 7 January 2011 / Published: 11 January 2011
(This article belongs to the Special Issue Opioids)
View Full-Text   |   Download PDF [311 KB, uploaded 11 January 2011]
Abstract: This review focuses on the physiological roles for kappa opioid receptors (KORs) in adult animals and humans, as well as in the developing newborn animal. Our recent findings have provided new information that under physiological conditions in conscious newborn animals, activation of KORs with the selective agonist, U-50488H, results in an aquaresis, as previously observed in adult animals and humans. In addition, we have shown in conscious lambs that KORs modulate systemic and renal haemodynamics as well as the arterial baroreflex control of heart rate, providing a previously unidentified role for KORs.
Keywords: kappa opioid peptides; KORs; newborn; physiology kappa opioid peptides; KORs; newborn; physiology
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Smith, F.G.; Qi, W. Cardiorenal Effects of Kappa Opioid Peptides During Ontogeny. Pharmaceuticals 2011, 4, 154-168.

AMA Style

Smith FG, Qi W. Cardiorenal Effects of Kappa Opioid Peptides During Ontogeny. Pharmaceuticals. 2011; 4(1):154-168.

Chicago/Turabian Style

Smith, Francine G.; Qi, Wei. 2011. "Cardiorenal Effects of Kappa Opioid Peptides During Ontogeny." Pharmaceuticals 4, no. 1: 154-168.



Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert